Responses
Regular and Young Investigator Award Abstracts
Novel Single-Agent Immunotherapies
1354 Anti-CCR8 antibody CHS-114 (SRF114) depletes tumor-infiltrating regulatory T cells in dissociated tumors from patients with head and neck squamous cell carcinoma
Compose a Response to This Article
Other responses
No responses have been published for this article.